We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PZG icon
4226
Paramount Gold Nevada
PZG
$125M
$6K ﹤0.01%
+4,444
New +$4.75K
QQXT icon
4227
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$159M
$6K ﹤0.01%
+97
New +$5.6K
SLF icon
4228
Sun Life Financial
SLF
$45.7B
$6K ﹤0.01%
162
+51
+46% +$1.75K
SND icon
4229
Smart Sand
SND
$200M
$6K ﹤0.01%
5,369
+22
+0.4% +$21
SNGX icon
4230
Soligenix
SNGX
$5.77M
$6K ﹤0.01%
+12
New +$4.95K
SPCE icon
4231
Virgin Galactic
SPCE
$398M
$6K ﹤0.01%
+19
New +$6.24K
NSLR
4232
Neostellar Capital Corp
NSLR
$248M
$6K ﹤0.01%
891
-6,285
-88% -$35.3K
TAIT
4233
DELISTED
Taitron Components
TAIT
$6K ﹤0.01%
+2,432
New +$6.02K
TTT icon
4234
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.5M
$6K ﹤0.01%
201
+126
+168% +$3.71K
VFH icon
4235
Vanguard Financials ETF
VFH
$13.8B
$6K ﹤0.01%
103
-1,059
-91% -$58.9K
VTGN icon
4236
VistaGen Therapeutics
VTGN
$12.2M
$6K ﹤0.01%
+406
New +$5.55K
WHLR
4237
Wheeler Real Estate Investment Trust
WHLR
$397K
0
QXO
4238
QXO Inc
QXO
$16.9B
$6K ﹤0.01%
+352
New +$5.72K
BLNE
4239
Beeline Holdings
BLNE
$33.8M
$6K ﹤0.01%
+19
New +$5.95K
BKCC
4240
DELISTED
BlackRock Capital Investment Corporation
BKCC
$6K ﹤0.01%
2,286
-2,473
-52% -$6.61K
CYAN
4241
DELISTED
Cyanotech Corp
CYAN
$6K ﹤0.01%
2,506
-380
-13% -$847
DCP
4242
DELISTED
DCP Midstream, LP
DCP
$6K ﹤0.01%
513
-2,970
-85% -$28.1K
UPH
4243
DELISTED
UpHealth, Inc.
UPH
$6K ﹤0.01%
+55
New +$5.51K
TUFN
4244
DELISTED
Tufin Software Technologies Ltd.
TUFN
$6K ﹤0.01%
649
-46,619
-99% -$446K
LEJU
4245
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$6K ﹤0.01%
+314
New +$5.51K
PTE
4246
DELISTED
PolarityTE, Inc. Common Stock
PTE
$6K ﹤0.01%
185
+139
+302% +$3.69K
BXRX
4247
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$6K ﹤0.01%
1
-1
-50% -$4.8K
TLGT
4248
DELISTED
Teligent, Inc
TLGT
$6K ﹤0.01%
+2,608
New +$9.19K
MDLY
4249
DELISTED
Medley Management Inc
MDLY
$6K ﹤0.01%
+808
New +$4.5K
NPAUU
4250
DELISTED
New Providence Acquisition Corp. Unit
NPAUU
$6K ﹤0.01%
598

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.